Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:58:26.352Z.
Calculation as of: 2026-10-06T19:58:26.352Z.
Quote observation: 2026-10-06T19:55:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 23d17170dcd90d56222e16e6e1c46ca5d6e49f0f5e08d353dc7d5f06f7b1586d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$9.63B
Operating Cash Flow Yield
2.83%
TTM Avg
2.60%
3Y Avg
2.63%
5Y Avg
2.63%
Market Cap
$9.66B
Operating Cash Flow Yield
7.24%
TTM Avg
6.59%
3Y Avg
7.11%
5Y Avg
6.80%
Market Cap
$9.88B
Operating Cash Flow Yield
1.37%
TTM Avg
1.59%
3Y Avg
1.73%
5Y Avg
1.57%
Market Cap
$9.93B
Operating Cash Flow Yield
4.96%
TTM Avg
6.18%
3Y Avg
5.41%
5Y Avg
4.43%
Market Cap
$9.33B
Operating Cash Flow Yield
5.48%
TTM Avg
4.05%
3Y Avg
2.43%
5Y Avg
1.96%
Market Cap
$10.03B
Operating Cash Flow Yield
6.07%
TTM Avg
5.15%
3Y Avg
4.87%
5Y Avg
5.29%
Market Cap
$9.21B
Operating Cash Flow Yield
2.07%
TTM Avg
1.91%
3Y Avg
2.90%
5Y Avg
2.85%
Market Cap
$10.15B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.66B | N/A | N/A | N/A | N/A |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | 2.83% | 2.60% | 2.63% | 2.63% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 7.24% | 6.59% | 7.11% | 6.80% |
| Repligen Corporation (RGEN)vs › | $9.88B | 1.37% | 1.59% | 1.73% | 1.57% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 4.96% | 6.18% | 5.41% | 4.43% |
| Insulet Corp. (PODD)vs › | $9.33B | 5.48% | 4.05% | 2.43% | 1.96% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 6.07% | 5.15% | 4.87% | 5.29% |
| Bruker Corporation (BRKR)vs › | $9.21B | 2.07% | 1.91% | 2.90% | 2.85% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 7.46% | 5.81% | 4.85% | 4.30% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
